Selected research
Market Structure
Global Neglected Tropical Diseases Drugs and Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Neglected Tropical Diseases Drugs and Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Neglected Tropical Diseases Drugs and Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Neglected Tropical Diseases Drugs and Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Neglected Tropical Diseases Drugs and Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Neglected Tropical Diseases Drugs and Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Neglected Tropical Diseases Drugs and Vaccine include Artecef BV, Cipla, Lupin, Macleods Pharmaceuticals, Ranbaxy Labs, Romark Laboratories, Sanofi-Aventis, Toyama Chemica and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Neglected Tropical Diseases Drugs and Vaccine market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Neglected Tropical Diseases Drugs and Vaccine and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Neglected Tropical Diseases Drugs and Vaccine revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Neglected Tropical Diseases Drugs and Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.
Neglected Tropical Diseases Drugs and Vaccine Segment by Company
Artecef BV
Cipla
Lupin
Macleods Pharmaceuticals
Ranbaxy Labs
Romark Laboratories
Sanofi-Aventis
Toyama Chemica
AstraZeneca
GlaxoSmithKline
Novartis
Neglected Tropical Diseases Drugs and Vaccine Segment by Type
Ebola
Dengue
Leishmaniasis
Chagas
Malaria
Other
Neglected Tropical Diseases Drugs and Vaccine Segment by Application
Drugs
Vaccines
Neglected Tropical Diseases Drugs and Vaccine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neglected Tropical Diseases Drugs and Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neglected Tropical Diseases Drugs and Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neglected Tropical Diseases Drugs and Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Neglected Tropical Diseases Drugs and Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neglected Tropical Diseases Drugs and Vaccine industry.
Chapter 3: Detailed analysis of Neglected Tropical Diseases Drugs and Vaccine companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neglected Tropical Diseases Drugs and Vaccinerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Ebola
- Dengue
- Leishmaniasis
- Chagas
- Malaria
- Other
Applications
- Drugs
- Vaccines
Companies covered
- Artecef BV
- Cipla
- Lupin
- Macleods Pharmaceuticals
- Ranbaxy Labs
- Romark Laboratories
- Sanofi-Aventis
- Toyama Chemica
- AstraZeneca
- GlaxoSmithKline
- Novartis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Ebola
- 1.2.3 Dengue
- 1.2.4 Leishmaniasis
- 1.2.5 Chagas
- 1.2.6 Malaria
- 1.2.7 Other
- 1.3 Market Analysis by Application
- 1.3.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Drugs
- 1.3.3 Vaccines
- 1.4 Global Market Growth Prospects
- 1.5 Global Neglected Tropical Diseases Drugs and Vaccine Growth Trends by Region
- 1.5.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2021-2026)
- 1.5.3 Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Neglected Tropical Diseases Drugs and Vaccine Market Dynamics
- 2.1 Neglected Tropical Diseases Drugs and Vaccine Industry Trends
- 2.2 Neglected Tropical Diseases Drugs and Vaccine Industry Drivers
- 2.3 Neglected Tropical Diseases Drugs and Vaccine Industry Opportunities and Challenges
- 2.4 Neglected Tropical Diseases Drugs and Vaccine Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Company (2021-2026)
- 3.2 Global Neglected Tropical Diseases Drugs and Vaccine Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Neglected Tropical Diseases Drugs and Vaccine Key Company Head office and Area Served
- 3.4 Global Neglected Tropical Diseases Drugs and Vaccine Company, Product Type & Application
- 3.5 Global Neglected Tropical Diseases Drugs and Vaccine Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Neglected Tropical Diseases Drugs and Vaccine Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Neglected Tropical Diseases Drugs and Vaccine Players Market Share by Revenue in 2025
- 3.6.3 2025 Neglected Tropical Diseases Drugs and Vaccine Tier 1, Tier 2, and Tier 3
4 Neglected Tropical Diseases Drugs and Vaccine Market by Type
- 4.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2021-2032)
- 4.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Share by Type (2021-2032)
5 Neglected Tropical Diseases Drugs and Vaccine Market by Application
- 5.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2021-2032)
- 5.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Artecef BV
- 6.1.1 Artecef BV Company Information
- 6.1.2 Artecef BV Business Overview
- 6.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
- 6.1.5 Artecef BV Recent Developments
- 6.2 Cipla
- 6.2.1 Cipla Company Information
- 6.2.2 Cipla Business Overview
- 6.2.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Cipla Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
- 6.2.5 Cipla Recent Developments
- 6.3 Lupin
- 6.3.1 Lupin Company Information
- 6.3.2 Lupin Business Overview
- 6.3.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Lupin Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
- 6.3.5 Lupin Recent Developments
- 6.4 Macleods Pharmaceuticals
- 6.4.1 Macleods Pharmaceuticals Company Information
- 6.4.2 Macleods Pharmaceuticals Business Overview
- 6.4.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
- 6.4.5 Macleods Pharmaceuticals Recent Developments
- 6.5 Ranbaxy Labs
- 6.5.1 Ranbaxy Labs Company Information
- 6.5.2 Ranbaxy Labs Business Overview
- 6.5.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
- 6.5.5 Ranbaxy Labs Recent Developments
- 6.6 Romark Laboratories
- 6.6.1 Romark Laboratories Company Information
- 6.6.2 Romark Laboratories Business Overview
- 6.6.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
- 6.6.5 Romark Laboratories Recent Developments
- 6.7 Sanofi-Aventis
- 6.7.1 Sanofi-Aventis Company Information
- 6.7.2 Sanofi-Aventis Business Overview
- 6.7.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
- 6.7.5 Sanofi-Aventis Recent Developments
- 6.8 Toyama Chemica
- 6.8.1 Toyama Chemica Company Information
- 6.8.2 Toyama Chemica Business Overview
- 6.8.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
- 6.8.5 Toyama Chemica Recent Developments
- 6.9 AstraZeneca
- 6.9.1 AstraZeneca Company Information
- 6.9.2 AstraZeneca Business Overview
- 6.9.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
- 6.9.5 AstraZeneca Recent Developments
- 6.10 GlaxoSmithKline
- 6.10.1 GlaxoSmithKline Company Information
- 6.10.2 GlaxoSmithKline Business Overview
- 6.10.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
- 6.10.5 GlaxoSmithKline Recent Developments
- 6.11 Novartis
- 6.11.1 Novartis Company Information
- 6.11.2 Novartis Business Overview
- 6.11.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Novartis Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
- 6.11.5 Novartis Recent Developments
7 North America
- 7.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size (2021-2032)
- 7.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
- 7.2.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2021-2026)
- 7.2.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2027-2032)
- 7.2.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2021-2032)
- 7.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
- 7.3.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2021-2026)
- 7.3.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2027-2032)
- 7.3.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2021-2032)
- 7.4 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
- 7.4.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2021-2026)
- 7.4.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2027-2032)
- 7.4.4 North America Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (2021-2032)
- 8.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
- 8.2.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2021-2026)
- 8.2.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2027-2032)
- 8.2.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2021-2032)
- 8.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
- 8.3.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2021-2026)
- 8.3.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2027-2032)
- 8.3.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2021-2032)
- 8.4 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
- 8.4.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2021-2026)
- 8.4.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2027-2032)
- 8.4.4 Europe Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Neglected Tropical Diseases Drugs and Vaccine Market Size (2021-2032)
- 9.2 China Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
- 9.2.1 China Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2021-2026)
- 9.2.2 China Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2027-2032)
- 9.2.3 China Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2021-2032)
- 9.3 China Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
- 9.3.1 China Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2021-2026)
- 9.3.2 China Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2027-2032)
- 9.3.3 China Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Neglected Tropical Diseases Drugs and Vaccine Market Size (2021-2032)
- 10.2 Asia Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
- 10.2.1 Asia Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2021-2026)
- 10.2.2 Asia Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2027-2032)
- 10.2.3 Asia Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2021-2032)
- 10.3 Asia Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
- 10.3.1 Asia Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2021-2026)
- 10.3.2 Asia Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2027-2032)
- 10.3.3 Asia Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2021-2032)
- 10.4 Asia Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
- 10.4.1 Asia Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2021-2026)
- 10.4.3 Asia Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2027-2032)
- 10.4.4 Asia Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
- 11.2.1 South America, Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
- 11.3.1 South America, Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
- 11.4.1 South America, Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst